Analysis of allergic immune responses in humanized mice

Cellular Immunology

Volumn 308, Issue , 2016, Pages 7-12

  Bellinghausen, Iris ^a   Saloga, Joachim ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Allergy; Colon; Humanized mice; IgE; Inflammation; Lung; Regulatory T cells

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CCL18 CHEMOKINE; CHEMOKINE; FC RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 35; INTERLEUKIN 4; INTERLEUKIN 5; OMALIZUMAB; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; CELL INTERACTION; COLITIS; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE MODEL; DRUG RESEARCH; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MAST CELL; MEDICAL RESEARCH; MEMORY CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE; SUBCUTANEOUS IMMUNOTHERAPY; T LYMPHOCYTE ACTIVATION; TH2 CELL; ANIMAL; DESENSITIZATION; FEMALE; HISTOCOMPATIBILITY; HYPERSENSITIVITY; IMMUNOLOGY; MALE; METABOLISM; PROCEDURES; REGULATORY T LYMPHOCYTE; SCID MOUSE; TRENDS;

ANIMALS; ASTHMA; BIOMEDICAL RESEARCH; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; MICE; MICE, SCID; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION CHIMERA;

EID: 84991577482     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2016.07.008     Document Type: Review

References (83)

1. [1] Akdis, M., Akdis, C.A., Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J. Allergy Clin. Immunol. 133 (2014), 621–631.
2. [2] de, S.D., Geromi, M., Panesar, S.S., Muraro, A., Werfel, T., Hoffmann-Sommergruber, K., Roberts, G., Cardona, V., Dubois, A.E., Halken, S., Host, A., Poulsen, L.K., van, R.R., Vlieg-Boerstra, B.J., Agache, I., Sheikh, A., Acute and long-term management of food allergy: systematic review. Allergy 69 (2014), 159–167.
3. [3] Akdis, C.A., Therapies for allergic inflammation: refining strategies to induce tolerance. Nat. Med. 18 (2012), 736–749.
4. [4] Sicherer, S.H., Leung, D.Y., Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2014. J. Allergy Clin. Immunol. 135 (2015), 357–367.
5. [5] Wisniewski, J., Agrawal, R., Woodfolk, J.A., Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts. Clin. Exp. Allergy 43 (2013), 164–176.
6. [6] Graham, M.T., Nadeau, K.C., Lessons learned from mice and man: mimicking human allergy through mouse models. Clin. Immunol. 155 (2014), 1–16.
7. [7] Takeda, K., Gelfand, E.W., Mouse models of allergic diseases. Curr. Opin. Immunol. 21 (2009), 660–665.
8. [8] Nguyen, T.H., Casale, T.B., Immune modulation for treatment of allergic disease. Immunol. Rev. 242 (2011), 258–271.
9. [9] Shultz, L.D., Ishikawa, F., Greiner, D.L., Humanized mice in translational biomedical research. Nat. Rev. Immunol. 7 (2007), 118–130.
10. [10] Shultz, L.D., Brehm, M.A., Garcia-Martinez, J.V., Greiner, D.L., Humanized mice for immune system investigation: progress, promise and challenges. Nat. Rev. Immunol. 12 (2012), 786–798.
11. [11] Brehm, M.A., Jouvet, N., Greiner, D.L., Shultz, L.D., Humanized mice for the study of infectious diseases. Curr. Opin. Immunol., 2013.
12. [12] Rongvaux, A., Takizawa, H., Strowig, T., Willinger, T., Eynon, E.E., Flavell, R.A., Manz, M.G., Human hemato-lymphoid system mice: current use and future potential for medicine. Annu. Rev. Immunol. 31 (2013), 635–674.
13. [13] Oettgen, H.C., Geha, R.S., IgE regulation and roles in asthma pathogenesis. J. Allergy Clin. Immunol. 107 (2001), 429–440.
14. [14] Paul, W.E., Zhu, J., How are T(H)2-type immune responses initiated and amplified?. Nat. Rev. Immunol. 10 (2010), 225–235.
15. [15] Lambrecht, B.N., Hammad, H., Allergens and the airway epithelium response: gateway to allergic sensitization. J. Allergy Clin. Immunol. 134 (2014), 499–507.
16. [16] Pellerin, L., Jenks, J.A., Begin, P., Bacchetta, R., Nadeau, K.C., Regulatory T cells and their roles in immune dysregulation and allergy. Immunol. Res., 2014.
17. [17] Palomares, O., Martin-Fontecha, M., Lauener, R., Traidl-Hoffmann, C., Cavkaytar, O., Akdis, M., Akdis, C.A., Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-beta. Genes Immun. 15 (2014), 511–520.
18. [18] Zhang, H., Kong, H., Zeng, X., Guo, L., Sun, X., He, S., Subsets of regulatory T cells and their roles in allergy. J. Transl. Med., 12, 2014, 125.
19. [19] Shevach, E.M., Thornton, A.M., TTregs, pTregs, and iTregs: similarities and differences. Immunol. Rev. 259 (2014), 88–102.
20. [20] Bellinghausen, I., Brand, U., Knop, J., Saloga, J., Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors. J. Allergy Clin. Immunol. 105 (2000), 988–996.
21. [21] Bellinghausen, I., Brand, U., Steinbrink, K., Enk, A.H., Knop, J., Saloga, J., Inhibition of human allergic T cell responses by interleukin-10-treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J. Allergy Clin. Immunol. 108 (2001), 242–249.
22. [22] Bellinghausen, I., König, B., Böttcher, I., Knop, J., Saloga, J., Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction. Clin. Exp. Allergy 36 (2006), 1546–1555.
23. [23] Bellinghausen, I., Klostermann, B., Knop, J., Saloga, J., Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J. Allergy Clin. Immunol. 111 (2003), 862–868.
24. [24] Bellinghausen, I., König, B., Böttcher, I., Knop, J., Saloga, J., Regulatory activity of human CD4+CD25+ T cells depends on allergen concentration, type of allergen and atopy status of the donor. Immunology 116 (2005), 103–111.
25. [25] Grindebacke, H., Wing, K., Andersson, A.C., Suri-Payer, E., Rak, S., Rudin, A., Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin. Exp. Allergy 34 (2004), 1364–1372.
26. [26] Ling, E.M., Smith, T., Nguyen, X.D., Pridgeon, C., Dallman, M., Arbery, J., Carr, V.A., Robinson, D.S., Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363 (2004), 608–615.
27. [27] Bellinghausen, I., Metz, G., Enk, A.H., Christmann, S., Knop, J., Saloga, J., Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur. J. Immunol. 27 (1997), 1131–1139.
28. [28] Jutel, M., Akdis, M., Budak, F., Aebischer-Casaulta, C., Wrzyszcz, M., Blaser, K., Akdis, C.A., IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 33 (2003), 1205–1214.
29. [29] Bellinghausen, I., Klostermann, B., Böttcher, I., Knop, J., Saloga, J., Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy. Immunology 112 (2004), 80–86.
30. [30] Akbari, O., Freeman, G.J., Meyer, E.H., Greenfield, E.A., Chang, T.T., Sharpe, A.H., Berry, G., DeKruyff, R.H., Umetsu, D.T., Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8 (2002), 1024–1032.
31. [31] Pierkes, M., Bellinghausen, I., Hultsch, T., Metz, G., Knop, J., Saloga, J., Decreased release of histamine and sulfido-leukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of interleukin-10 and interferon-gamma production of T cells. J. Allergy Clin. Immunol. 103:2 Pt 1 (1999), 326–332.
32. [32] Ross, R., Sudowe, S., Beisner, J., Ross, X.L., Ludwig-Portugall, I., Steitz, J., Tuting, T., Knop, J., Reske-Kunz, A.B., Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin. Gene Ther. 10 (2003), 1035–1040.
33. [33] Ross, R., Jonuleit, H., Bros, M., Ross, X.L., Yamashiro, S., Matsumura, F., Enk, A.H., Knop, J., Reske-Kunz, A.B., Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation. J. Invest. Dermatol. 115 (2000), 658–663.
34. [34] Sudowe, S., Ludwig-Portugall, I., Montermann, E., Ross, R., Reske-Kunz, A.B., Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells. J. Allergy Clin. Immunol. 117 (2006), 196–203.
35. [35] Ludwig-Portugall, I., Montermann, E., Kremer, A., Reske-Kunz, A.B., Sudowe, S., Prevention of long-term IgE antibody production by gene gun-mediated DNA vaccination. J. Allergy Clin. Immunol. 114 (2004), 951–957.
36. [36] Zindler, E., Gehrke, N., Luft, C., Reuter, S., Taube, C., Finotto, S., Reske-Kunz, A.B., Sudowe, S., Divergent effects of biolistic gene transfer in a mouse model of allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 38 (2008), 38–46.
37. [37] Raker, V., Stein, J., Montermann, E., Maxeiner, J., Taube, C., Reske-Kunz, A.B., Sudowe, S., Regulation of IgE production and airway reactivity by CD4(−)CD8(−) regulatory T cells. Immunobiology 220 (2015), 490–499.
38. [38] Barwig, C., Raker, V., Montermann, E., Grabbe, S., Reske-Kunz, A.B., Sudowe, S., Antigen dose-dependent suppression of murine IgE responses is mediated by CD4(−)CD8(−) double-negative T cells. Clin. Exp. Allergy 40 (2010), 891–901.
39. [39] Steinbrink, K., Sorg, C., Macher, E., Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells. J. Exp. Med. 183 (1996), 759–768.
40. [40] Seidel-Guyenot, W., Perschon, S., Dechant, N., Alt, R., Knop, J., Steinbrink, K., Low zone tolerance induced by systemic application of allergens inhibits Tc1-mediated skin inflammation. J. Allergy Clin. Immunol. 117 (2006), 1170–1177.
41. [41] Luckey, U., Schmidt, T., Pfender, N., Romer, M., Lorenz, N., Martin, S.F., Bopp, T., Schmitt, E., Nikolaev, A., Yogev, N., Waisman, A., Jakob, T., Steinbrink, K., Crosstalk of regulatory T cells and tolerogenic dendritic cells prevents contact allergy in subjects with low zone tolerance. J. Allergy Clin. Immunol. 130 (2012), 781–797.
42. [42] Luckey, U., Maurer, M., Schmidt, T., Lorenz, N., Seebach, B., Metz, M., Steinbrink, K., T cell killing by tolerogenic dendritic cells protects mice from allergy. J. Clin. Invest. 121 (2011), 3860–3871.
43. [43] Bellinghausen, I., Sudowe, S., König, B., Reske-Kunz, A.B., Knop, J., Saloga, J., Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice. Int. Arch. Allergy Immunol. 141 (2006), 61–69.
44. [44] Brehm, M.A., Shultz, L.D., Luban, J., Greiner, D.L., Overcoming current limitations in humanized mouse research. J. Infect. Dis. 208:Suppl. 2 (2013), S125–S130.
45. [45] Mosier, D.E., Gulizia, R.J., Baird, S.M., Wilson, D.B., Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335 (1988), 256–259.
46. [46] McCune, J.M., Namikawa, R., Kaneshima, H., Shultz, L.D., Lieberman, M., Weissman, I.L., The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241 (1988), 1632–1639.
47. [47] Duez, C., Tsicopoulos, A., Janin, A., Tillie-Leblond, I., Thyphronitis, G., Marquillies, P., Hamid, Q., Wallaert, B., Tonnel, A.B., Pestel, J., An in vivo model of allergic inflammation: pulmonary human cell infiltrate in allergen-challenged allergic Hu-SCID mice. Eur. J. Immunol. 26 (1996), 1088–1093.
48. [48] Jarman, E.R., Perschke, K., Montermann, E., Herz, U., Renz, H., Knop, J., Reske-Kunz, A.B., Deficient cytokine response of human allergen-specific T lymphocytes from humanized SCID mice and reconstitution by professional antigen-presenting cells. J. Allergy Clin. Immunol. 105 (2000), 967–974.
49. [49] Herz, U., Daser, A., Renz, H., The humanized (Hu-PBMC) SCID mouse as an in vivo model for human IgE production and allergic inflammation of the skin. Int. Arch. Allergy Immunol. 113 (1997), 150–152.
50. [50] Hammad, H., Lambrecht, B.N., Pochard, P., Gosset, P., Marquillies, P., Tonnel, A.B., Pestel, J., Monocyte-derived dendritic cells induce a house dust mite-specific Th2 allergic inflammation in the lung of humanized SCID mice: involvement of CCR7. J. Immunol. 169 (2002), 1524–1534.
51. [51] Carballido, J.M., Schols, D., Namikawa, R., Zurawski, S., Zurawski, G., Roncarolo, M.G., de Vries, J.E., IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist. J. Immunol. 155 (1995), 4162–4170.
52. [52] Carballido, J.M., Biedermann, T., Schwarzler, C., de Vries, J.E., The SCID-hu Skin mouse as a model to investigate selective chemokine mediated homing of human T-lymphocytes to the skin in vivo. J. Immunol. Methods 273 (2003), 125–135.
53. [53] Ito, R., Takahashi, T., Katano, I., Kawai, K., Kamisako, T., Ogura, T., Ida-Tanaka, M., Suemizu, H., Nunomura, S., Ra, C., Mori, A., Aiso, S., Ito, M., Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice. J. Immunol. 191 (2013), 2890–2899.
54. [54] Duez, C., Gras-Masse, H., Hammad, H., Akoum, H., Didierlaurent, A., Andre, C., Tonnel, A.B., Pestel, J., Modulation of the allergen-induced human IgE response in Hu-SCID mice: inhibitory effect of human recombinant IFN-gamma and allergen-derived lipopeptide. Eur. Cytokine Netw. 12 (2001), 453–461.
55. [55] Pestel, J., Jeannin, P., Delneste, Y., Dessaint, J.P., Cesbron, J.Y., Capron, A., Tsicopoulos, A., Tonnel, A.B., Human IgE in SCID mice reconstituted with peripheral blood mononuclear cells from Dermatophagoides pteronyssinus-sensitive patients. J. Immunol. 153 (1994), 3804–3810.
56. [56] Gagnon, R., Boutin, Y., Hebert, J., Lol p I-specific IgE and IgG synthesis by peripheral blood mononuclear cells from atopic subjects in SCID mice. J. Allergy Clin. Immunol. 95 (1995), 1268–1275.
57. [57] Herz, U., Botchkarev, V.A., Paus, R., Renz, H., Increased airway responsiveness, allergy-type-I skin responses and systemic anaphylaxis in a humanized-severe combined immuno-deficiency mouse model. Clin. Exp. Allergy 34 (2004), 478–487.
58. [58] Perros, F., Hoogsteden, H.C., Coyle, A.J., Lambrecht, B.N., Hammad, H., Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation. Allergy 64 (2009), 995–1002.
59. [59] Sonar, S.S., Hsu, Y.M., Conrad, M.L., Majeau, G.R., Kilic, A., Garber, E., Gao, Y., Nwankwo, C., Willer, G., Dudda, J.C., Kim, H., Bailly, V., Pagenstecher, A., Rennert, P.D., Renz, H., Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma. J. Clin. Invest. 120 (2010), 2767–2781.
60. [60] Noma, T., Yoshizawa, I., Kawano, Y., Matsuura, N., Nakajima, T., Aoki, K., Functional human IgE specific for Dermatophagoides farinae antigen is produced in SCID mice reconstituted with peripheral mononuclear cells derived from healthy persons and patients with asthma. Allergy 56 (2001), 1137–1143.
61. [61] Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., Ueyama, Y., Koyanagi, Y., Sugamura, K., Tsuji, K., Heike, T., Nakahata, T., NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100 (2002), 3175–3182.
62. [62] King, M., Pearson, T., Shultz, L.D., Leif, J., Bottino, R., Trucco, M., Atkinson, M.A., Wasserfall, C., Herold, K.C., Woodland, R.T., Schmidt, M.R., Woda, B.A., Thompson, M.J., Rossini, A.A., Greiner, D.L., A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin. Immunol. 126 (2008), 303–314.
63. [63] Macchiarini, F., Manz, M.G., Palucka, A.K., Shultz, L.D., Humanized mice: are we there yet?. J. Exp. Med. 202 (2005), 1307–1311.
64. [64] Weigmann, B., Schughart, N., Wiebe, C., Sudowe, S., Lehr, H.A., Jonuleit, H., Vogel, L., Becker, C., Neurath, M.F., Grabbe, S., Saloga, J., Bellinghausen, I., Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergy. J. Allergy Clin. Immunol. 129 (2012), 1126–1135.
65. [65] Martin, H., Reuter, S., Dehzad, N., Heinz, A., Bellinghausen, I., Saloga, J., Haasler, I., Korn, S., Jonuleit, H., Buhl, R., Becker, C., Taube, C., CD4-mediated regulatory T-cell activation inhibits the development of disease in a humanized mouse model of allergic airway disease. J. Allergy Clin. Immunol. 129 (2012), 521–528.
66. [66] Albert, D.H., Malo, P.E., Tapang, P., Shaughnessy, T.K., Morgan, D.W., Wegner, C.D., Curtin, M.L., Sheppard, G.S., Xu, L., Davidsen, S.K., Summers, J.B., Carter, G.W., The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis. J. Pharmacol. Exp. Ther. 284 (1998), 83–88.
67. [67] Arias, K., Baig, M., Colangelo, M., Chu, D., Walker, T., Goncharova, S., Coyle, A., Vadas, P., Waserman, S., Jordana, M., Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions. J. Allergy Clin. Immunol. 124 (2009), 307–314.
68. [68] Willinger, T., Rongvaux, A., Takizawa, H., Yancopoulos, G.D., Valenzuela, D.M., Murphy, A.J., Auerbach, W., Eynon, E.E., Stevens, S., Manz, M.G., Flavell, R.A., Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 2390–2395.
69. [69] Tasaki, Y., Fukuda, S., Iio, M., Miura, R., Imai, T., Sugano, S., Yoshie, O., Hughes, A.L., Nomiyama, H., Chemokine PARC gene (SCYA18) generated by fusion of two MIP-1alpha/LD78alpha-like genes. Genomics 55 (1999), 353–357.
70. [70] Bellinghausen, I., Reuter, S., Martin, H., Maxeiner, J., Luxemburger, U., Tureci, O., Grabbe, S., Taube, C., Saloga, J., Enhanced production of CCL18 by tolerogenic dendritic cells is associated with inhibition of allergic airway reactivity. J. Allergy Clin. Immunol. 130 (2012), 1384–1393.
71. [71] Azzaoui, I., Yahia, S.A., Chang, Y., Vorng, H., Morales, O., Fan, Y., Delhem, N., Ple, C., Tonnel, A.B., Wallaert, B., Tsicopoulos, A., CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects. Blood 118 (2011), 3549–3558.
72. [72] Vulcano, M., Struyf, S., Scapini, P., Cassatella, M., Bernasconi, S., Bonecchi, R., Calleri, A., Penna, G., Adorini, L., Luini, W., Mantovani, A., Van Damme, J., Sozzani, S., Unique regulation of CCL18 production by maturing dendritic cells. J. Immunol. 170 (2003), 3843–3849.
73. [73] Wang, R., Kozhaya, L., Mercer, F., Khaitan, A., Fujii, H., Unutmaz, D., Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 13439–13444.
74. [74] Tran, D.Q., Andersson, J., Wang, R., Ramsey, H., Unutmaz, D., Shevach, E.M., GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 13445–13450.
75. [75] Eschborn, M., Weigmann, B., Reissig, S., Waisman, A., Saloga, J., Bellinghausen, I., Activated glycoprotein A repetitions predominant (GARP)-expressing regulatory T cells inhibit allergen-induced intestinal inflammation in humanized mice. J. Allergy Clin. Immunol. 136 (2015), 159–168.
76. [76] Hahn, S.A., Stahl, H.F., Becker, C., Correll, A., Schneider, F.J., Tuettenberg, A., Jonuleit, H., Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4(+) T cells. Blood 122 (2013), 1182–1191.
77. [77] Becker, C., Taube, C., Bopp, T., Becker, C., Michel, K., Kubach, J., Reuter, S., Dehzad, N., Neurath, M.F., Reifenberg, K., Schneider, F.J., Schmitt, E., Jonuleit, H., Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells. Blood 114 (2009), 1263–1269.
78. [78] Collison, L.W., Workman, C.J., Kuo, T.T., Boyd, K., Wang, Y., Vignali, K.M., Cross, R., Sehy, D., Blumberg, R.S., Vignali, D.A., The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 (2007), 566–569.
79. [79] Whitehead, G.S., Wilson, R.H., Nakano, K., Burch, L.H., Nakano, H., Cook, D.N., IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J. Allergy Clin. Immunol. 129 (2012), 207–215.
80. [80] Dong, J., Wong, C.K., Cai, Z., Jiao, D., Chu, M., Lam, C.W., Amelioration of allergic airway inflammation in mice by regulatory IL-35 through dampening inflammatory dendritic cells. Allergy 70 (2015), 921–932.
81. [81] Gamazo, C., Gastaminza, G., Ferrer, M., Sanz, M.L., Irache, J.M., Nanoparticle based-immunotherapy against allergy. Immunotherapy. 6 (2014), 885–897.
82. [82] Pohlit, H., Bellinghausen, I., Schomer, M., Heydenreich, B., Saloga, J., Frey, H., Biodegradable pH-sensitive poly(ethylene glycol) nanocarriers for allergen encapsulation and controlled release. Biomacromolecules, 2015.
83. [83] Petzelbauer, P., Groger, M., Kunstfeld, R., Petzelbauer, E., Wolff, K., Human delayed-type hypersensitivity reaction in a SCID mouse engrafted with human T cells and autologous skin. J. Invest. Dermatol. 107 (1996), 576–581.